已收盘 09-18 16:00:00 美东时间
+0.160
+1.50%
inTest (AMEX:INTT) affirms FY2026 sales outlook from $135.000 million-$140.000 million to $135.000 million-$140.000 million vs $138.948 million estimate.
08-10 18:16
inTest (AMEX:INTT) sees Q3 sales of $33.000 million-$35.000 million vs $35.068 million analyst estimate.
08-10 18:16
inTest (AMEX:INTT) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.05 by 80 percent. This is a 200 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $35.300 million which beat the a...
08-10 18:16
InTest’s Q2 2026 revenue increased 25.5% year over year to $35.3 million, while diluted GAAP EPS improved to $0.04 from a $0.04 loss. Auto/EV revenue more than doubled and drove the quarter’s growth, but the shift toward lower-margin projects reduced gross margin by 210 basis points to 40.5%. Adjusted EBITDA rose 73.7% to $2.2 million, and operating cash flow reached $6.3 million. Backlog remained 19.8% above last year at $45.4 million, while the
08-10 10:22
inTest (AMEX:INTT) raises Q2 Prelim sales outlook from $32.000 million-$34.000 million to $35.000 million vs $33.013 million estimate.
07-31 20:27
inTest (AMEX:INTT) raises FY2026 Prelim sales outlook from $130.000 million-$135.000 million to $135.000 million-$140.000 million vs $133.911 million estimate.
07-31 20:26
InTest Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include Semiconductor, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced that it has been a...
06-29 21:06
Shares of semiconductor and chip companies are trading lower as robust U.S. pay...
06-06 02:56
inTest shares are trading lower. The company reported its Q1 financial results.
05-05 23:33
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12